Scarica l'app Stockscreener
9.985
4.45%
0.425
Precedente Chiudi:
$9.56
Aprire:
$9.64
Volume 24 ore:
15,373
Relative Volume:
1.02
Capitalizzazione di mercato:
$85.50M
Reddito:
-
Utile/perdita netta:
$-53.45M
Rapporto P/E:
-0.4599
EPS:
-21.71
Flusso di cassa netto:
$-31.81M
1 W Prestazione:
-8.73%
1M Prestazione:
+14.64%
6M Prestazione:
+2.94%
1 anno Prestazione:
+39.65%
Intervallo 1D:
$9.545
$10.90
Intervallo di 1 settimana:
$9.03
$10.95
Portata 52W:
$5.90
$18.17
Surrozen Inc Stock (SRZN) Company Profile
Nome
Surrozen Inc
Settore
Industria
Telefono
650-475-2820
Indirizzo
171 OYSTER POINT BLVD, SOUTH SAN FRANCISCO
Confronta SRZN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SRZN
Surrozen Inc
|
9.985 | 81.86M | 0 | -53.45M | -31.81M | -21.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
374.46 | 93.98B | 11.42B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
435.00 | 57.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.94 | 59.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
638.90 | 40.50B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
289.75 | 34.26B | 3.81B | -644.79M | -669.77M | -6.24 |
Surrozen Inc Stock (SRZN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-30 | Iniziato | H.C. Wainwright | Buy |
| 2025-01-03 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2021-10-11 | Iniziato | BofA Securities | Buy |
| 2021-09-15 | Iniziato | Guggenheim | Buy |
| 2021-09-07 | Iniziato | Stifel | Buy |
Surrozen Inc Borsa (SRZN) Ultime notizie
Detecting price anomalies in Surrozen Inc. with AIEquity Portfolio Outlook and Performance Summary - Newser
What makes Surrozen Inc. Equity Warrant stock price move sharplyEntry Opportunity Screener with Confirmation - Newser
What MACD and RSI say about Surrozen Inc. Equity WarrantFree Proven Entry Plan With Low Risk Trade - Newser
What technical models suggest about Surrozen Inc. Equity Warrant’s comebackConsistent Return Setup with Exit Strategy - Newser
Can Surrozen Inc. Equity Warrant hit a new high this monthMarket Ready Picks with Technical Support - Newser
Why Surrozen Inc. Equity Warrant stock attracts strong analyst attentionFree Trade Timing Strategy With Technical Data - Newser
Surrozen Inc. stock chart pattern explainedReversal Signal Prediction Based on Volume - Newser
Has Surrozen Inc. formed a bullish divergenceAI Trend Detection for Entry Timing - Newser
Analyzing net buyer seller activity in Surrozen Inc. Equity WarrantFree Smart Trade Plans With Risk Protection - Newser
How to forecast Surrozen Inc. trends using time seriesLow Drawdown Stock Screener with Analysis - Newser
Key metrics from Surrozen Inc.’s quarterly dataGrowth Projection Summary for Long-Term Investors - Newser
How to build a custom watchlist for Surrozen Inc.3-Day Market Movement Forecast Analysis - Newser
Using R and stats models for Surrozen Inc. Equity Warrant forecastingDownside Risk Evaluation and Stock Analysis - Newser
Surrozen Inc.’s volatility index tracking explainedROI Prediction from Long-Term Holding Plans - Newser
Does Surrozen Inc. show high probability of reboundRisk Aware Trading Ideas with Alert Levels - Newser
Developing predictive dashboards with Surrozen Inc. dataFree Risk Controlled Short Term Trade Plans - Newser
Surrozen Inc. Equity Warrant stock trend forecastValue Holding Return Summary With Outlook - Newser
Is Surrozen Inc. building a consolidation basePredicted Market Direction Based on Momentum - Newser
How to manage a losing position in Surrozen Inc. Equity WarrantDaily Investment Ideas with Market Insight - Newser
Can trapped investors hope for a rebound in Surrozen Inc. Equity WarrantLow Risk Trade Timing with Analysis Metrics - Newser
Surrozen Inc. Equity Warrant stock chart pattern explained7-Day Equity Return Range Forecast Model - Newser
Surrozen's Q2 2025 Earnings: A Biotech Turnaround Driven by Strategic Gains and Ophthalmology Pipeline Progress - AInvest
Technical analysis overview for Surrozen Inc. stockFree Real Time Alerts Based on AI Prediction - Newser
What indicators show strength in Surrozen Inc. Equity WarrantTechnical Screener for High Growth Stocks - Newser
Published on: 2025-08-09 11:37:11 - beatles.ru
Surrozen’s Q2 2025: Progress in Eye Disease Therapies - MSN
Is Surrozen Inc. Equity Warrant stock ready for a breakoutReal-Time Equity Price Action Analysis - Newser
Surrozen Inc. Equity Warrant recovery potential after sell offLong Term Stock Planner with Safety Checks - Newser
Surrozen Reports Q2 Profit on Gains - AOL.com
Surrozen WRT SRZNW 2025Q2 Earnings Preview Upside Potential on Revenue Growth and New Product Launch - AInvest
European Equity Fund, Inc. shares rise 1.52% after-hours following recent financial results from Canopy Growth and Surrozen. - AInvest
Surrozen Reports Q2 Profit on Gains - The Motley Fool
Surrozen Flips To Profit And Draws Bullish Analyst Buzz - Finimize
Surrozen posts Q2 net income of $39.7 mln - MarketScreener
Surrozen Reports Second Quarter 2025 Financial Results and Provides Business Update - Morningstar
Why Surrozen Inc. stock attracts strong analyst attentionTechnical Chart Summary for Momentum Stocks - Newser
Surrozen Inc Azioni (SRZN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.02%
3.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):